TCM Biotech International Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	685.49	666.53	969.62	802.42	702.05
Revenue Growth (YoY)	2.84%	-31.26%	20.84%	14.30%	-4.75%
Cost of Revenue	368.5	339.22	489.45	353.93	343.33
Gross Profit	316.99	327.31	480.17	448.49	358.72
Selling, General & Admin	210.57	224.09	380.38	340.9	276.14
Research & Development	88.42	93.22	77.46	81.8	80.45
Operating Expenses	298.34	316.61	457.84	423.19	356.59
Operating Income	18.65	10.7	22.33	25.3	2.13
Interest Expense	-0.86	-1.61	-2.77	-2.39	-1.97
Interest & Investment Income	5.69	4.69	1.55	0.14	0.04
Currency Exchange Gain (Loss)	-	-	-	0.01	0.44
Other Non Operating Income (Expenses)	-1.18	11.24	0.93	0.07	0.71
EBT Excluding Unusual Items	22.3	25.02	22.03	23.13	1.35
Gain (Loss) on Sale of Assets	-	-	-	-	0.91
Pretax Income	22.3	25.02	22.03	23.13	2.26
Income Tax Expense	3.13	4.01	3.46	4.86	0.38
Net Income	19.17	21.01	18.57	18.27	1.87
Net Income to Common	19.17	21.01	18.57	18.27	1.87
Net Income Growth	-8.76%	13.11%	1.69%	875.17%	-92.67%
Shares Outstanding (Basic)	60	59	53	49	49
Shares Outstanding (Diluted)	60	59	53	49	49
Shares Change (YoY)	1.40%	11.37%	8.03%	0.89%	0.42%
EPS (Basic)	0.32	0.36	0.35	0.37	0.04
EPS (Diluted)	0.32	0.36	0.35	0.37	0.04
EPS Growth	-10.06%	1.66%	-5.41%	861.49%	-92.66%
Free Cash Flow	34.65	159.42	-41.51	48.46	11.19
Free Cash Flow Per Share	0.58	2.70	-0.78	0.99	0.23
Dividend Per Share	-	0.350	0.285	0.033	-
Dividend Growth	-	22.81%	763.64%	-	-
Gross Margin	46.24%	49.11%	49.52%	55.89%	51.10%
Operating Margin	2.72%	1.60%	2.30%	3.15%	0.30%
Profit Margin	2.80%	3.15%	1.92%	2.28%	0.27%
Free Cash Flow Margin	5.05%	23.92%	-4.28%	6.04%	1.59%
EBITDA	42.85	28.61	39.52	40.86	16.42
EBITDA Margin	6.25%	4.29%	4.08%	5.09%	2.34%
D&A For EBITDA	24.2	17.92	17.19	15.56	14.29
EBIT	18.65	10.7	22.33	25.3	2.13
EBIT Margin	2.72%	1.60%	2.30%	3.15%	0.30%
Effective Tax Rate	14.03%	16.02%	15.70%	21.02%	17.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.